| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
3,593 |
2,430 |
$2.41M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
12,791 |
9,547 |
$789K |
| J9035 |
Injection, bevacizumab, 10 mg |
7,904 |
5,131 |
$255K |
| 92134 |
|
12,882 |
10,106 |
$158K |
| 67228 |
|
176 |
132 |
$55K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,200 |
2,507 |
$45K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
835 |
597 |
$21K |
| 92235 |
|
384 |
330 |
$19K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
291 |
228 |
$9K |
| 92250 |
|
710 |
590 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
200 |
158 |
$7K |
| 2024F |
|
89 |
81 |
$130.00 |
| 2026F |
|
89 |
81 |
$130.00 |
| 2022F |
|
89 |
81 |
$130.00 |
| 1036F |
|
197 |
156 |
$0.07 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
88 |
80 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
197 |
156 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
75 |
67 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
278 |
221 |
$0.00 |
| 2021F |
|
111 |
98 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
124 |
110 |
$0.00 |
| 5010F |
|
88 |
80 |
$0.00 |
| 4040F |
|
32 |
26 |
$0.00 |